Key Players in Pharmaceutical Contract Manufacturing: Market developments, outsourcing hotspots and growth strategies–Aarkstore Enterprise
Aarkstore announce a new report “Key Players in Pharmaceutical Contract Manufacturing: Market developments, outsourcing hotspots and growth strategies” through its vast collection of market research report.This report aims to identify the hotspots and profile the leading players in the global pharmaceutical contract manufacturing market. It analyses company developments in the light of industry size, industry structure, service offerings, new technologies, major strategies and competitive situation, to discern trends of the industry as well its major players. It also analyses the current market scenario to identify the hotspots for contract manufacturing.
Market development
Catalent
Lonza
Boehringer Ingelheim (BI)
DSM
Evonik
Patheon
Piramal
Jubilant
Aenova
Fareva
What is this report about?
Methodology
Summary
Overview
Market size and growth
Positioning and performance of leading players
Drivers of manufacturing outsourcing
Key trends in the market
Increasing offshore outsourcing by Big Pharma
Expansion of biopharmaceutical contract manufacturing
Industry consolidation
Contract manufacturing hotspots – India and China
India
Contract manufacturing in India
Key CMOs in India
China
Contract Manufacturing in China
Key CMOs in China
Comparison of India and China on key parameters
Availability of skilled labor
Cost
Manufacturing infrastructure
Global capabilities
Service portfolio
Concerns about offshoring
Summary
Company overview
Group structure
Oral Technologies
Sterile Technologies
Packaging Services
Recent financial performance
Performance by business segments
Oral Technologies
Sterile Technologies
Packaging Services
Performance by geographies
Manufacturing and R&D
Acquisitions and divestments
Growth strategies
Summary
Company overview
Group structure
Life Science Ingredients
Exclusive Synthesis & Biopharmaceuticals
Bioscience
Recent financial performance
Performance by business segments
Manufacturing and R&D
Acquisitions and divestments
Growth strategies
Capacity expansion
Strategic partnerships and acquisitions
High value products
Summary
Company overview
Group structure
Biopharmaceuticals
Pharmaceuticals Production
Pharma Chemicals
Recent financial performance
Performance by business segments
Manufacturing and R&D
Acquisitions and divestments
Growth strategies
Capacity expansion
Strategic partnerships
Summary
Company overview
Group structure
Recent financial performance
Manufacturing and R&D
Acquisitions and divestments
Growth strategies
Summary
Company overview
Group structure
Recent financial performance
Manufacturing and R&D
Acquisitions and divestments
Growth strategies
Restructuring of operations
Geographic restructuring
Capacity expansion
Geographic expansion
Summary
Company overview
Group structure
Commercial Manufacturing
Pharmaceutical Development Services (PDS)
Recent financial performance
Performance by business segments
Performance by geographies
Manufacturing and R&D
Acquisitions and divestments
Growth strategies
Focus on prescription drugs business
Improve profitability and capacity utilization
Diversify customer base
Summary
Company overview
Group structure
PDS (Pharmaceutical Development Services)
PMS (Pharmaceutical Manufacturing Services)
MMBB (Manufacturing Molecules/ Building Blocks)
Others
Recent financial performance
Performance by business segments
Manufacturing and R&D
Acquisitions and divestments
Growth strategies
Summary
Company overview
Group structure
Recent financial performance
Performance by product segments
Performance by geographies
Manufacturing and R&D
Acquisitions and divestments
Growth strategies
Summary
Company overview
Group structure
Swiss Caps
Dragenopharm
Recent financial performance
Manufacturing and R&D
Acquisitions and divestments
Growth strategies
Summary
Company overview
Group structure
Recent financial performance
Manufacturing and R&D
Acquisitions and divestments
Growth strategies
Nipro
Company overview
Recent financial performance
Siegfried
Company description
Recent financial performance
Haupt
Company description
Recent financial performance
Divi’s Laboratories (Divi’s)
Company description
Recent financial performance
Cambrex
Company description
Recent financial performance
Recipharm
Company description
Recent financial performance
Archimica
Company description
Vetter
Company description
Famar
Company description
NextPharma
Company description
Other contract manufacturers
Index
Figure 2.1: Global pharmaceutical contract manufacturing market size, 2007-2011
Figure 2.2: Positioning of leading players (2007)*
Figure 2.3: Labor cost in select countries
Figure 2.4: No. of FDA approved plants outside the US, 2007
Figure 3.5: Catalent’s financial performance ($m), 2004-2008*
Figure 3.6: Catalent’s revenue break-up by geography (%), 2008
Figure 4.7: Lonza’s contract manufacturing financial performance ($m), 2005-2007*
Figure 5.8: BI Industrial Customers’ financial performance ($m), 2005-2007*
Figure 6.9: DSM DPP’s financial performance ($m), 2005-2007*
Figure 7.10: Evonik’s Health & Nutrition financial performance ($m), 2006-2007*
Figure 8.11: Patheon’s financial performance ($m), 2006-2008*
Figure 8.12: Patheon’s Commercial Manufacturing revenue break-up by geography (%), 2008*
Figure 9.13: Piramal Pharma Solutions’ financial performance ($m), 2006-2007*
Figure 10.14: Jubilant’s CRAMS financial performance ($m), 2003-2007*
Figure 10.15: Jubilant’s revenue break-up by geography (%), 2007*
Figure 12.16: Fareva Pharmaceuticals’ financial performance ($m), 2006-2008*
Table 2.1: Leading pharmaceutical contract manufacturing companies, 2007
Table 2.2: Select manufacturing outsourcing initiatives planned by the Big Pharma
Table 2.3: Leading CMOs in India
Table 2.4: Select foreign acquisitions by Indian players
Table 2.5: Manufacturing cost comparison
Table 3.6: Catalent’s snapshot
Table 3.7: Catalent’s financial performance ($m), 2004-2008
Table 3.8: Catalent’s business segments performance ($m), 2006-2008
Table 3.9: Catalent’s performance by geography ($m), 2006-2008
Table 4.10: Lonza’s snapshot
Table 4.11: Lonza’s contract manufacturing financial performance ($m), 2005-2007
Table 4.12: Lonza’s contract manufacturing business segments performance ($m), 2005-2007
Table 5.13: BI’s snapshot
Table 5.14: BI Industrial Customers’ financial performance ($m), 2005-2007
Table 5.15: BI Industrial Customers’ business segments performance ($m), 2005-2007
Table 6.16: DSM’s snapshot
Table 6.17: DSM DPP’s financial performance ($m), 2005-2007
Table 7.18: Evonik’s snapshot
Table 7.19: Evonik’s Health & Nutrition financial performance ($m), 2006-2007
Table 8.20: Patheon’s snapshot
Table 8.21: Patheon’s financial performance ($m), 2006-2008
Table 8.22: Patheon’s business segments performance ($m), 2008
Table 8.23: Patheon’s Commercial Manufacturing performance by geography ($m), 2007-2008
Table 9.24: Piramal’s snapshot
Table 9.25: Piramal Pharma Solutions’ financial performance ($m), 2006-2007
Table 9.26: Piramal Pharma Solutions’ business segments performance ($m), 2005-2007
Table 10.27: Jubilant’s snapshot
Table 10.28: Jubilant’s CRAMS financial performance ($m), 2003-2007
Table 10.29: Jubilant’s CRAMS product segments performance ($m), 2006-2007
Table 10.30: Jubilant’s performance by geography ($m), 2005-2007
Table 11.31: Aenova’s snapshot
Table 12.32: Fareva’s snapshot
Table 12.33: Fareva Pharmaceuticals’ financial performance ($m), 2006-2008
Table 13.34: Nipro’s snapshot
Table 13.35: Nipro’s Pharmaceutical financial performance ($m), 2003-2007 *
Table 13.36: Siegfried’s snapshot
Table 13.37: Siegfried’s financial performance ($m), 2006-2007*
Table 13.38: Haupt’s snapshot
Table 13.39: Divi’s’ snapshot
Table 13.40: Divi’s financial performance ($m), 2003-2007
Table 13.41: Cambrex’s snapshot
Table 13.42: Cambrex’s financial performance ($m), 2005-2007*
Table 13.43: Recipharm’s snapshot
Table 13.44: Recipharm’s financial performance ($m), 2003-2008
Table 13.45: Archimica’s snapshot
Table 13.46: Vetter’s snapshot
Table 13.47: Famar’s snapshot
Table 13.48: NextPharma’s snapshot
Table 13.49: Other select contract manufacturers
For more information, please visit :http://www.aarkstore.com/reports/Key-Players-in-Pharmaceutical-Contract-Manufacturing-Market-developments-outsourcing-hotspots-and-growth-strategies-13982.htmlOr email us at press@aarkstore.com or call +919272852585
Powered By Rxid.com
whitesmoke software
